These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 20132397

  • 21. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M.
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 24. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.
    Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Timing of arrhythmic death after myocardial infarction: does it affect timing of ICD implantation?
    Lombardi F.
    Eur Heart J; 2005 Jul 15; 26(14):1350-2. PubMed ID: 15872027
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II).
    Gandjour A, Holler A, Dipl-Ges-Ök, Adarkwah CC.
    Value Health; 2011 Jul 15; 14(6):812-7. PubMed ID: 21914500
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P.
    Circulation; 2009 Jul 21; 120(3):194-200. PubMed ID: 19581496
    [Abstract] [Full Text] [Related]

  • 36. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML, MADIT-II Investigators.
    J Am Coll Cardiol; 2008 Jan 22; 51(3):288-96. PubMed ID: 18206738
    [Abstract] [Full Text] [Related]

  • 37. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
    Trappe HJ, Pfitzner P, Achtelik M, Fieguth HG.
    Heart; 1997 Oct 22; 78(4):364-70. PubMed ID: 9404252
    [Abstract] [Full Text] [Related]

  • 38. Temporal aspects of improved survival with the implanted defibrillator (MADIT-II).
    Moss AJ, Vyas A, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, McNitt SA, Andrews ML, MADIT-II Research Group.
    Am J Cardiol; 2004 Aug 01; 94(3):312-5. PubMed ID: 15276094
    [Abstract] [Full Text] [Related]

  • 39. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.
    Ottervanger JP, Ramdat Misier AR, Zijlstra F, Schalij MJ, Wever E, Jordaens LJ, Henriques JP, de Boer MJ, Robbe HW, Wellens HJ, DAPA Investigators.
    Am Heart J; 2006 Oct 01; 152(4):636-40. PubMed ID: 16996827
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.